These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32468716)

  • 1. The CRISPR babies controversy: Responsibility and regulation in the spotlight.
    Meyer M
    EMBO Rep; 2020 Jul; 21(7):e50307. PubMed ID: 32468716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human germline editing in the era of CRISPR-Cas: risk and uncertainty, inter-generational responsibility, therapeutic legitimacy.
    Schleidgen S; Dederer HG; Sgodda S; Cravcisin S; Lüneburg L; Cantz T; Heinemann T
    BMC Med Ethics; 2020 Sep; 21(1):87. PubMed ID: 32912206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why CRISPR babies are still too risky - embryo studies highlight challenges.
    Ledford H
    Nature; 2023 Mar; 615(7953):568-569. PubMed ID: 36914863
    [No Abstract]   [Full Text] [Related]  

  • 4. A society-wide conversation is needed about germline genome editing using CRISPR.
    Birney E
    Nat Med; 2024 Jan; 30(1):30-32. PubMed ID: 38177854
    [No Abstract]   [Full Text] [Related]  

  • 5. Clustered Regularly Interspaced Short Palindromic Repeats System of Genome Engineering in Embryos to Repair Genes.
    Niazvand F; Fathinezhad Z; Alfuraiji N; Etajuri EA; Amini-Chermahini F; Chehelgerdi M; Ranjbar R
    J Biomed Nanotechnol; 2021 Mar; 17(3):331-356. PubMed ID: 33875070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Embryonic Regulation and Research: What Is the Status of Human Germline Genome Editing in Australia?
    Burbery R
    J Law Med; 2020 Apr; 27(3):718-740. PubMed ID: 32406632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The trust game: CRISPR for human germline editing unsettles scientists and society.
    Braun M; Meacham D
    EMBO Rep; 2019 Feb; 20(2):. PubMed ID: 30602586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upstream Ethical Mapping of Germline Genome Editing.
    Halpern J; Paolo D
    Am J Bioeth; 2020 Aug; 20(8):1-4. PubMed ID: 32804067
    [No Abstract]   [Full Text] [Related]  

  • 9. The Council of Europe should not reaffirm the ban on germline genome editing in humans.
    Sykora P; Caplan A
    EMBO Rep; 2017 Nov; 18(11):1871-1872. PubMed ID: 28986351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Off- and on-target effects of genome editing in mouse embryos.
    Ayabe S; Nakashima K; Yoshiki A
    J Reprod Dev; 2019 Feb; 65(1):1-5. PubMed ID: 30518723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
    Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
    Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. After the fact-the case of CRISPR babies.
    Sand M; Bredenoord AL; Jongsma KR
    Eur J Hum Genet; 2019 Nov; 27(11):1621-1624. PubMed ID: 31235868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ordo-Responsibility for Germline Gene Editing.
    Ranisch R; Rudolph T; Cremer HJ; Knoepffler N
    CRISPR J; 2020 Feb; 3(1):37-43. PubMed ID: 32091257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Human Right to Science and the Regulation of Human Germline Engineering.
    Boggio A; Knoppers BM; Almqvist J; Romano CPR
    CRISPR J; 2019 Jun; 2():134-142. PubMed ID: 31225756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. China focuses on ethics to deter another 'CRISPR babies' scandal.
    Mallapaty S
    Nature; 2022 May; 605(7908):15-16. PubMed ID: 35478023
    [No Abstract]   [Full Text] [Related]  

  • 17. Genome editing using CRISPR, CAST, and Fanzor systems.
    Song B; Bae S
    Mol Cells; 2024 Jul; 47(7):100086. PubMed ID: 38909984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Promise of CRISPR for Human Germline Editing and the Perils of "Playing God".
    Locke LG
    CRISPR J; 2020 Feb; 3(1):27-31. PubMed ID: 32091254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-P 2.0: An Improved CRISPR-Cas9 Tool for Genome Editing in Plants.
    Liu H; Ding Y; Zhou Y; Jin W; Xie K; Chen LL
    Mol Plant; 2017 Mar; 10(3):530-532. PubMed ID: 28089950
    [No Abstract]   [Full Text] [Related]  

  • 20. Strategies for Optimization of the Clustered Regularly Interspaced Short Palindromic Repeat-Based Genome Editing System for Enhanced Editing Specificity.
    Wang YM; Wang HZ; Jian YZ; Luo ZT; Shao HW; Zhang WF
    Hum Gene Ther; 2022 Apr; 33(7-8):358-370. PubMed ID: 34963339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.